

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ATP synthesis coupled proton transport (GO:0015986) | 5.18148073 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.18148073 |
| 3 | positive regulation of respiratory burst (GO:0060267) | 5.02648337 |
| 4 | DNA deamination (GO:0045006) | 4.90799694 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.89926492 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.36224332 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.09725296 |
| 8 | viral transcription (GO:0019083) | 3.93080261 |
| 9 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.84005941 |
| 10 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.84005941 |
| 11 | protein neddylation (GO:0045116) | 3.75773603 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74166810 |
| 13 | translational termination (GO:0006415) | 3.72923058 |
| 14 | positive regulation of prostaglandin secretion (GO:0032308) | 3.67743566 |
| 15 | electron transport chain (GO:0022900) | 3.65395334 |
| 16 | respiratory electron transport chain (GO:0022904) | 3.64521135 |
| 17 | cytidine deamination (GO:0009972) | 3.59879946 |
| 18 | cytidine metabolic process (GO:0046087) | 3.59879946 |
| 19 | cytidine catabolic process (GO:0006216) | 3.59879946 |
| 20 | behavioral response to nicotine (GO:0035095) | 3.48646417 |
| 21 | regulation of regulatory T cell differentiation (GO:0045589) | 3.47798743 |
| 22 | chaperone-mediated protein transport (GO:0072321) | 3.43219464 |
| 23 | fucose catabolic process (GO:0019317) | 3.42396516 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.42396516 |
| 25 | L-fucose catabolic process (GO:0042355) | 3.42396516 |
| 26 | protein complex biogenesis (GO:0070271) | 3.40305635 |
| 27 | maturation of SSU-rRNA (GO:0030490) | 3.35548360 |
| 28 | ubiquinone biosynthetic process (GO:0006744) | 3.30995308 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.27765378 |
| 30 | translational elongation (GO:0006414) | 3.27404639 |
| 31 | protein targeting to ER (GO:0045047) | 3.27233099 |
| 32 | sulfation (GO:0051923) | 3.25380463 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 3.25045768 |
| 34 | ribosomal small subunit biogenesis (GO:0042274) | 3.21823405 |
| 35 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.20700898 |
| 36 | respiratory chain complex IV assembly (GO:0008535) | 3.17277306 |
| 37 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.16140884 |
| 38 | positive regulation of fatty acid transport (GO:2000193) | 3.15722624 |
| 39 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.13818071 |
| 40 | cytochrome complex assembly (GO:0017004) | 3.13409644 |
| 41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11427592 |
| 42 | regulation of immunoglobulin secretion (GO:0051023) | 3.10817056 |
| 43 | rRNA modification (GO:0000154) | 3.09895313 |
| 44 | protein localization to endoplasmic reticulum (GO:0070972) | 3.09785391 |
| 45 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.08513055 |
| 46 | quinone biosynthetic process (GO:1901663) | 3.08225230 |
| 47 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.07415488 |
| 48 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.03522718 |
| 49 | NADH dehydrogenase complex assembly (GO:0010257) | 3.03522718 |
| 50 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.03522718 |
| 51 | regulation of prostaglandin secretion (GO:0032306) | 3.02773308 |
| 52 | cellular response to interferon-beta (GO:0035458) | 3.02622234 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.02052537 |
| 54 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00749823 |
| 55 | protein-cofactor linkage (GO:0018065) | 2.98537232 |
| 56 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.97818003 |
| 57 | ATP biosynthetic process (GO:0006754) | 2.95089129 |
| 58 | antibacterial humoral response (GO:0019731) | 2.95017807 |
| 59 | ribosomal large subunit biogenesis (GO:0042273) | 2.93968694 |
| 60 | hydrogen ion transmembrane transport (GO:1902600) | 2.93596488 |
| 61 | kynurenine metabolic process (GO:0070189) | 2.92807170 |
| 62 | ubiquinone metabolic process (GO:0006743) | 2.92256539 |
| 63 | negative regulation of B cell apoptotic process (GO:0002903) | 2.92243431 |
| 64 | positive regulation of icosanoid secretion (GO:0032305) | 2.89524058 |
| 65 | rRNA catabolic process (GO:0016075) | 2.88100564 |
| 66 | positive regulation of defense response to virus by host (GO:0002230) | 2.86044186 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 2.85842464 |
| 68 | tryptophan catabolic process (GO:0006569) | 2.85842464 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 2.85842464 |
| 70 | response to interferon-beta (GO:0035456) | 2.85724982 |
| 71 | regulation of guanylate cyclase activity (GO:0031282) | 2.83163400 |
| 72 | viral life cycle (GO:0019058) | 2.80265858 |
| 73 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.79886166 |
| 74 | proton transport (GO:0015992) | 2.79798327 |
| 75 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.79345053 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.77919970 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.77919970 |
| 78 | hydrogen transport (GO:0006818) | 2.77156031 |
| 79 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.76311374 |
| 80 | arginine metabolic process (GO:0006525) | 2.74322247 |
| 81 | regulation of respiratory burst (GO:0060263) | 2.72621193 |
| 82 | vitamin biosynthetic process (GO:0009110) | 2.68864452 |
| 83 | translation (GO:0006412) | 2.66599192 |
| 84 | cellular response to exogenous dsRNA (GO:0071360) | 2.66257213 |
| 85 | drug catabolic process (GO:0042737) | 2.66214592 |
| 86 | cellular protein complex disassembly (GO:0043624) | 2.65975280 |
| 87 | antimicrobial humoral response (GO:0019730) | 2.64938198 |
| 88 | mannosylation (GO:0097502) | 2.64846065 |
| 89 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.63748779 |
| 90 | kidney morphogenesis (GO:0060993) | 2.63747394 |
| 91 | pseudouridine synthesis (GO:0001522) | 2.63510865 |
| 92 | piRNA metabolic process (GO:0034587) | 2.60512956 |
| 93 | translational initiation (GO:0006413) | 2.58597613 |
| 94 | proteasome assembly (GO:0043248) | 2.57362545 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 2.57041196 |
| 96 | cellular component biogenesis (GO:0044085) | 2.51079996 |
| 97 | negative regulation of mast cell activation (GO:0033004) | 2.51033637 |
| 98 | rRNA methylation (GO:0031167) | 2.49223031 |
| 99 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.46845141 |
| 100 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.46091261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.55520450 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52736542 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.47726277 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17831473 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.14638002 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.04641804 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.95474102 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.72726849 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.67635292 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.67467746 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.54981594 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48094505 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.47870360 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.44939128 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.40762207 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07247630 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.06567469 |
| 18 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.83301264 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77917622 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75240506 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74864578 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67340982 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67010836 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66566088 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66154768 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.66116693 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65645821 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63664849 |
| 29 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.62980568 |
| 30 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.62980568 |
| 31 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.60790615 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.60637772 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59383562 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55827753 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54842728 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53071644 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50755870 |
| 38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48543589 |
| 39 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.42528724 |
| 40 | AR_20517297_ChIP-Seq_VCAP_Human | 1.41644015 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40595277 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.40463126 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39596851 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39514093 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39311422 |
| 46 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.39174926 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38078964 |
| 48 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.34026993 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33538187 |
| 50 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32535043 |
| 51 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32056201 |
| 52 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.30351830 |
| 53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.29516349 |
| 54 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.28822116 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28765644 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28765644 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28544149 |
| 58 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27805237 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25503205 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24686213 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23938274 |
| 62 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.23099880 |
| 63 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.22672766 |
| 64 | ERA_21632823_ChIP-Seq_H3396_Human | 1.19053505 |
| 65 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.18079462 |
| 66 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16873306 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16659277 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.15017255 |
| 69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.14736690 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12802373 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.09923372 |
| 72 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.09494173 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06251718 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.05880449 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04963503 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.04551286 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04396323 |
| 78 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02753137 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01819495 |
| 80 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.01478019 |
| 81 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.01423228 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01401875 |
| 83 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01368971 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01283441 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00179331 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00013170 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99397682 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96722353 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95799062 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95110318 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94475890 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94298068 |
| 93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93966493 |
| 94 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.93562633 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92987201 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92909418 |
| 97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.92879568 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92287747 |
| 99 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90767233 |
| 100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89483586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.42109495 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 4.02139375 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.19827195 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.83914290 |
| 5 | MP0005360_urolithiasis | 2.61040791 |
| 6 | MP0000685_abnormal_immune_system | 2.60543470 |
| 7 | MP0005671_abnormal_response_to | 2.47782937 |
| 8 | MP0002876_abnormal_thyroid_physiology | 2.27150357 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.23579498 |
| 10 | MP0008872_abnormal_physiological_respon | 2.18923472 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14737327 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.03574111 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 1.96211034 |
| 14 | MP0002102_abnormal_ear_morphology | 1.92498318 |
| 15 | MP0003646_muscle_fatigue | 1.86199619 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 1.85010896 |
| 17 | MP0001790_abnormal_immune_system | 1.82286259 |
| 18 | MP0005387_immune_system_phenotype | 1.82286259 |
| 19 | MP0010155_abnormal_intestine_physiology | 1.81605601 |
| 20 | MP0001968_abnormal_touch/_nociception | 1.78719334 |
| 21 | MP0001800_abnormal_humoral_immune | 1.74198397 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.70593371 |
| 23 | MP0003718_maternal_effect | 1.70187542 |
| 24 | MP0003724_increased_susceptibility_to | 1.67771606 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.67738328 |
| 26 | MP0009764_decreased_sensitivity_to | 1.64788621 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.63274646 |
| 28 | MP0001293_anophthalmia | 1.59483720 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.53171582 |
| 30 | MP0002736_abnormal_nociception_after | 1.48537227 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.45678594 |
| 32 | MP0004885_abnormal_endolymph | 1.42124036 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.39949001 |
| 34 | MP0003252_abnormal_bile_duct | 1.32711549 |
| 35 | MP0004147_increased_porphyrin_level | 1.31936402 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.29720684 |
| 37 | MP0002723_abnormal_immune_serum | 1.26475865 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.26336337 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.26079984 |
| 40 | MP0004142_abnormal_muscle_tone | 1.25163735 |
| 41 | MP0003878_abnormal_ear_physiology | 1.24735384 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.24735384 |
| 43 | MP0003866_abnormal_defecation | 1.24691886 |
| 44 | MP0009785_altered_susceptibility_to | 1.23500630 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.21001681 |
| 46 | MP0003011_delayed_dark_adaptation | 1.20836239 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.18656326 |
| 48 | MP0003283_abnormal_digestive_organ | 1.18128158 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.16420913 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.12912151 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.12690960 |
| 52 | MP0002272_abnormal_nervous_system | 1.12331477 |
| 53 | MP0001663_abnormal_digestive_system | 1.11515342 |
| 54 | MP0005389_reproductive_system_phenotype | 1.09807747 |
| 55 | MP0001873_stomach_inflammation | 1.09763135 |
| 56 | MP0001819_abnormal_immune_cell | 1.09428035 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.07897006 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.06947801 |
| 59 | MP0005025_abnormal_response_to | 1.05604281 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.04735467 |
| 61 | MP0001919_abnormal_reproductive_system | 1.04659665 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.04604189 |
| 63 | MP0000604_amyloidosis | 1.03477183 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.02191779 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.01628070 |
| 66 | MP0005365_abnormal_bile_salt | 0.99904377 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.96358289 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.96115068 |
| 69 | MP0005332_abnormal_amino_acid | 0.92893208 |
| 70 | MP0001905_abnormal_dopamine_level | 0.92881408 |
| 71 | MP0008775_abnormal_heart_ventricle | 0.91771070 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.91661788 |
| 73 | MP0000427_abnormal_hair_cycle | 0.90785212 |
| 74 | MP0003436_decreased_susceptibility_to | 0.89052780 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.88708189 |
| 76 | MP0002163_abnormal_gland_morphology | 0.88643227 |
| 77 | MP0002006_tumorigenesis | 0.88615581 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.88080822 |
| 79 | MP0010329_abnormal_lipoprotein_level | 0.87428806 |
| 80 | MP0003195_calcinosis | 0.86958984 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.86441791 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.85769031 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.85262017 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.82998386 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.82641882 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.82312516 |
| 87 | MP0002160_abnormal_reproductive_system | 0.79838710 |
| 88 | MP0003786_premature_aging | 0.78397944 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.77364425 |
| 90 | MP0002938_white_spotting | 0.77185898 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.76179210 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.75906959 |
| 93 | MP0009745_abnormal_behavioral_response | 0.75501172 |
| 94 | MP0000716_abnormal_immune_system | 0.75160016 |
| 95 | MP0004043_abnormal_pH_regulation | 0.74875166 |
| 96 | MP0003879_abnormal_hair_cell | 0.74294956 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.73693209 |
| 98 | MP0000538_abnormal_urinary_bladder | 0.72826957 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.72607387 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.71829956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 3-Methylglutaconic aciduria (HP:0003535) | 3.98562358 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.84700190 |
| 3 | IgG deficiency (HP:0004315) | 3.78653949 |
| 4 | Acute encephalopathy (HP:0006846) | 3.54826442 |
| 5 | Congenital, generalized hypertrichosis (HP:0004540) | 3.53719954 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.52271851 |
| 7 | Pancreatic cysts (HP:0001737) | 3.45488043 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27038244 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.25291225 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.23869466 |
| 11 | Increased CSF lactate (HP:0002490) | 3.20878482 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.14124930 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.09972850 |
| 14 | Congenital stationary night blindness (HP:0007642) | 2.99220910 |
| 15 | True hermaphroditism (HP:0010459) | 2.98683219 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.89274715 |
| 17 | Stomatitis (HP:0010280) | 2.87562889 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.86966908 |
| 19 | Hepatocellular necrosis (HP:0001404) | 2.85621689 |
| 20 | Pendular nystagmus (HP:0012043) | 2.85396372 |
| 21 | Hyperglycinemia (HP:0002154) | 2.85261402 |
| 22 | Abnormality of B cell number (HP:0010975) | 2.82026470 |
| 23 | Cerebral edema (HP:0002181) | 2.80797301 |
| 24 | Increased IgM level (HP:0003496) | 2.77607576 |
| 25 | Reticulocytopenia (HP:0001896) | 2.72423824 |
| 26 | Abnormal biliary tract physiology (HP:0012439) | 2.71688430 |
| 27 | Bile duct proliferation (HP:0001408) | 2.71688430 |
| 28 | Glycosuria (HP:0003076) | 2.69332984 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 2.69332984 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 2.66976234 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.66976234 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65583252 |
| 33 | Methylmalonic aciduria (HP:0012120) | 2.64792875 |
| 34 | Hepatic necrosis (HP:0002605) | 2.61716085 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.61317763 |
| 36 | Nephronophthisis (HP:0000090) | 2.53821752 |
| 37 | B lymphocytopenia (HP:0010976) | 2.53016866 |
| 38 | Abnormal number of erythroid precursors (HP:0012131) | 2.48464780 |
| 39 | Confusion (HP:0001289) | 2.46905815 |
| 40 | Decreased central vision (HP:0007663) | 2.46296209 |
| 41 | Methylmalonic acidemia (HP:0002912) | 2.43558365 |
| 42 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.41325416 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37437871 |
| 44 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.37105364 |
| 45 | Lethargy (HP:0001254) | 2.36769329 |
| 46 | Type II lissencephaly (HP:0007260) | 2.34500103 |
| 47 | Increased serum lactate (HP:0002151) | 2.33954446 |
| 48 | Optic disc pallor (HP:0000543) | 2.32960223 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.31934824 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.31934824 |
| 51 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30895170 |
| 52 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30568211 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.29321706 |
| 54 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.27877793 |
| 55 | Macrocytic anemia (HP:0001972) | 2.25440476 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.24901197 |
| 57 | Absent thumb (HP:0009777) | 2.24745333 |
| 58 | Exertional dyspnea (HP:0002875) | 2.24708285 |
| 59 | Lactic acidosis (HP:0003128) | 2.23996733 |
| 60 | Increased corneal curvature (HP:0100692) | 2.23025684 |
| 61 | Keratoconus (HP:0000563) | 2.23025684 |
| 62 | Hyperglycinuria (HP:0003108) | 2.21329112 |
| 63 | Hypoplasia of the uterus (HP:0000013) | 2.19167655 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.17791785 |
| 65 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.17466880 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.16228372 |
| 67 | Abnormality of the renal medulla (HP:0100957) | 2.15700417 |
| 68 | Cystic liver disease (HP:0006706) | 2.14740493 |
| 69 | Pancytopenia (HP:0001876) | 2.13605791 |
| 70 | Sclerocornea (HP:0000647) | 2.12265793 |
| 71 | Thyroiditis (HP:0100646) | 2.10318328 |
| 72 | Eosinophilia (HP:0001880) | 2.09119328 |
| 73 | Abnormality of vitamin B metabolism (HP:0004340) | 2.07886595 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.04890776 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.03438254 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.01468820 |
| 77 | Alveolar cell carcinoma (HP:0006519) | 1.99870521 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 1.99244692 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 1.95582659 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95582659 |
| 81 | Abnormality of eosinophils (HP:0001879) | 1.94431637 |
| 82 | Hyperphosphaturia (HP:0003109) | 1.93191989 |
| 83 | IgM deficiency (HP:0002850) | 1.92225089 |
| 84 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91777772 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 1.89992735 |
| 86 | Septo-optic dysplasia (HP:0100842) | 1.88566607 |
| 87 | Metabolic alkalosis (HP:0200114) | 1.87307544 |
| 88 | Asplenia (HP:0001746) | 1.84116991 |
| 89 | Colon cancer (HP:0003003) | 1.82166191 |
| 90 | IgA deficiency (HP:0002720) | 1.80255940 |
| 91 | Polydipsia (HP:0001959) | 1.80250149 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.80250149 |
| 93 | Ketosis (HP:0001946) | 1.79822824 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.78839294 |
| 95 | Attenuation of retinal blood vessels (HP:0007843) | 1.77947882 |
| 96 | Male pseudohermaphroditism (HP:0000037) | 1.77625863 |
| 97 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.77000338 |
| 98 | Tubular atrophy (HP:0000092) | 1.76730248 |
| 99 | Respiratory failure (HP:0002878) | 1.73613559 |
| 100 | Hypoproteinemia (HP:0003075) | 1.73493750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.75265929 |
| 2 | TLK1 | 3.45291722 |
| 3 | NUAK1 | 3.31480096 |
| 4 | ACVR1B | 2.88331956 |
| 5 | ZAK | 2.85099083 |
| 6 | FRK | 2.64337479 |
| 7 | ADRBK2 | 2.62698836 |
| 8 | VRK2 | 2.58068892 |
| 9 | TXK | 2.48387128 |
| 10 | GRK1 | 2.36269130 |
| 11 | WNK4 | 2.21933614 |
| 12 | MAP4K2 | 2.13801929 |
| 13 | BCKDK | 1.83649724 |
| 14 | EIF2AK3 | 1.77387564 |
| 15 | PINK1 | 1.74477268 |
| 16 | STK16 | 1.70701681 |
| 17 | NEK1 | 1.68333089 |
| 18 | KIT | 1.64112055 |
| 19 | OXSR1 | 1.49090243 |
| 20 | GRK6 | 1.40307533 |
| 21 | FES | 1.38472505 |
| 22 | TEC | 1.38047676 |
| 23 | DYRK2 | 1.34746008 |
| 24 | NME1 | 1.33150349 |
| 25 | MAPKAPK3 | 1.31849598 |
| 26 | CDK19 | 1.31636149 |
| 27 | STK39 | 1.28771804 |
| 28 | VRK1 | 1.27613521 |
| 29 | MST4 | 1.24337338 |
| 30 | EIF2AK1 | 1.22687826 |
| 31 | WNK3 | 1.21963597 |
| 32 | MAP2K2 | 1.19280728 |
| 33 | IKBKB | 1.14640557 |
| 34 | KDR | 1.09448765 |
| 35 | ITK | 1.07155859 |
| 36 | MAP4K1 | 1.05814496 |
| 37 | RPS6KA5 | 0.98938266 |
| 38 | SRPK1 | 0.96335144 |
| 39 | MAP3K14 | 0.88351013 |
| 40 | PHKG2 | 0.85824558 |
| 41 | PHKG1 | 0.85824558 |
| 42 | TNIK | 0.85519683 |
| 43 | PRKCQ | 0.84443950 |
| 44 | SYK | 0.83559045 |
| 45 | MKNK1 | 0.82000835 |
| 46 | INSRR | 0.79922491 |
| 47 | TIE1 | 0.78475650 |
| 48 | ADRBK1 | 0.77129303 |
| 49 | LYN | 0.74646289 |
| 50 | IKBKE | 0.74002525 |
| 51 | MAPK13 | 0.73873773 |
| 52 | MAPKAPK5 | 0.72637235 |
| 53 | PIK3CA | 0.72028177 |
| 54 | MUSK | 0.71859126 |
| 55 | MAP2K6 | 0.71617476 |
| 56 | EIF2AK2 | 0.71007682 |
| 57 | CDC7 | 0.70784652 |
| 58 | PLK3 | 0.70434778 |
| 59 | MKNK2 | 0.68946012 |
| 60 | NEK2 | 0.68809789 |
| 61 | PLK2 | 0.68282031 |
| 62 | LCK | 0.66086731 |
| 63 | BCR | 0.65644565 |
| 64 | BMPR1B | 0.62711165 |
| 65 | BTK | 0.62533926 |
| 66 | FLT3 | 0.60600512 |
| 67 | TAF1 | 0.57364369 |
| 68 | PRKCE | 0.55855722 |
| 69 | BUB1 | 0.55143293 |
| 70 | TESK2 | 0.51830581 |
| 71 | AURKB | 0.51702514 |
| 72 | PRKCG | 0.51430729 |
| 73 | PRKCA | 0.51354288 |
| 74 | CSF1R | 0.51281588 |
| 75 | NME2 | 0.50768886 |
| 76 | SIK2 | 0.49629183 |
| 77 | PLK4 | 0.49247484 |
| 78 | PRKCD | 0.48216380 |
| 79 | MAP3K12 | 0.47919421 |
| 80 | PLK1 | 0.46722100 |
| 81 | CAMKK2 | 0.46590312 |
| 82 | CSNK2A1 | 0.46538447 |
| 83 | PDK2 | 0.46521738 |
| 84 | GRK5 | 0.45025065 |
| 85 | PRKACA | 0.43281863 |
| 86 | TNK2 | 0.42646999 |
| 87 | PRKCI | 0.41834559 |
| 88 | JAK3 | 0.41338914 |
| 89 | CSNK1G2 | 0.40672194 |
| 90 | CSNK2A2 | 0.40603736 |
| 91 | MATK | 0.40530288 |
| 92 | PRKCH | 0.39710433 |
| 93 | PASK | 0.39611206 |
| 94 | PIM1 | 0.39335851 |
| 95 | RPS6KA6 | 0.39267186 |
| 96 | IGF1R | 0.38901365 |
| 97 | RPS6KA4 | 0.37914955 |
| 98 | CSNK1A1 | 0.37414033 |
| 99 | MYLK | 0.35264069 |
| 100 | PRKACG | 0.33653355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.04928303 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.42405421 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.10504054 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.05639090 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.94712714 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.92647671 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.77986844 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44279498 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.35990065 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.31747884 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.10863589 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.10133467 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.07685468 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.81236679 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80302757 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.77401638 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75963252 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73476492 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65163985 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64472884 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52282044 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44927869 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44519846 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.40216837 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39834836 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37353413 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34143697 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30811737 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30487971 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29834367 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29265362 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.28636046 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23100042 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20818521 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20464738 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.18618434 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.15793017 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14967768 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12516709 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11414867 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10879257 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08520555 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.06468371 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05490881 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05090656 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98035791 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97811329 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97042113 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92308932 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91553233 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90683615 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88015478 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87055300 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86425986 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85078313 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80739590 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80724247 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79661850 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.77338838 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75964937 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.75444842 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75230382 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73962611 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68763977 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.68695550 |
| 66 | Mismatch repair_Homo sapiens_hsa03430 | 0.68444875 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68187297 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67508870 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67292662 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65046503 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64708800 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64310191 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63845501 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62112037 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61983657 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.60147949 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58405831 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54464232 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50659290 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48954680 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48079496 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46156636 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.45709167 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45602458 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43570372 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43364081 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43020643 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41818641 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40516054 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39300460 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38055496 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37981861 |
| 93 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34406971 |
| 94 | DNA replication_Homo sapiens_hsa03030 | 0.31560905 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30501856 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.28831141 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.27838283 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25609827 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.25458819 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24943218 |

